149 related articles for article (PubMed ID: 11406663)
1. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment.
Cochran AJ; Morton DL; Stern S; Lana AM; Essner R; Wen DR
Mod Pathol; 2001 Jun; 14(6):604-8. PubMed ID: 11406663
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
Lee JH; Torisu-Itakara H; Cochran AJ; Kadison A; Huynh Y; Morton DL; Essner R
Clin Cancer Res; 2005 Jan; 11(1):107-12. PubMed ID: 15671534
[TBL] [Abstract][Full Text] [Related]
3. Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma.
Vuylsteke RJ; Molenkamp BG; Gietema HA; van Leeuwen PA; Wijnands PG; Vos W; van Diest PJ; Scheper RJ; Meijer S; de Gruijl TD
Cancer Res; 2004 Nov; 64(22):8456-60. PubMed ID: 15548718
[TBL] [Abstract][Full Text] [Related]
4. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
Scheri RP; Essner R; Turner RR; Ye X; Morton DL
Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
[TBL] [Abstract][Full Text] [Related]
5. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours.
Cochran AJ; Roberts A; Wen DR; Huang RR; Itakura E; Luo F; Binder SW
Pathology; 2004 Oct; 36(5):478-84. PubMed ID: 15370119
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
[TBL] [Abstract][Full Text] [Related]
7. Surgical and molecular approaches to the sentinel lymph nodes.
Essner R; Kojima M
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):31S-34S. PubMed ID: 11599894
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.
Torisu-Itakura H; Lee JH; Scheri RP; Huynh Y; Ye X; Essner R; Morton DL
Clin Cancer Res; 2007 Jun; 13(11):3125-32. PubMed ID: 17545514
[TBL] [Abstract][Full Text] [Related]
9. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
Thies A; Berlin A; Brunner G; Schulze HJ; Moll I; Pfüller U; Wagener C; Schachner M; Altevogt P; Schumacher U
Cancer Lett; 2007 Apr; 248(1):68-80. PubMed ID: 16822608
[TBL] [Abstract][Full Text] [Related]
10. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell function in sentinel nodes.
Essner R; Kojima M
Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):27-31. PubMed ID: 11829280
[TBL] [Abstract][Full Text] [Related]
12. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
13. Selective Modulation of Paracortical Dendritic Cells and T-Lymphocytes in Breast Cancer Sentinel Lymph Nodes.
Huang RR; Wen DR; Guo J; Giuliano AE; Nguyen M; Offodile R; Stern S; Turner R; Cochran AJ
Breast J; 2000 Jul; 6(4):225-232. PubMed ID: 11348370
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
15. Effect of melanoma on immune function in the regional lymph node basin.
Negin B; Panka D; Wang W; Siddiqui M; Tawa N; Mullen J; Tahan S; Mandato L; Polivy A; Mier J; Atkins M
Clin Cancer Res; 2008 Feb; 14(3):654-9. PubMed ID: 18245524
[TBL] [Abstract][Full Text] [Related]
16. Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma.
Essner R
Cancer Metastasis Rev; 2006 Jun; 25(2):257-67. PubMed ID: 16770538
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy and melanoma biology.
Essner R
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
[TBL] [Abstract][Full Text] [Related]
18. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node.
Cochran AJ; Wen DR; Huang RR; Wang HJ; Elashoff R; Morton DL
Mod Pathol; 2004 Jul; 17(7):747-55. PubMed ID: 15098011
[TBL] [Abstract][Full Text] [Related]
19. The detection and significance of melanoma micrometastases in sentinel nodes.
Scolyer RA; Murali R; Satzger I; Thompson JF
Surg Oncol; 2008 Sep; 17(3):165-74. PubMed ID: 18639451
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes.
Gerlini G; Urso C; Mariotti G; Di Gennaro P; Palli D; Brandani P; Salvadori A; Pimpinelli N; Reali UM; Borgognoni L
Clin Immunol; 2007 Nov; 125(2):184-93. PubMed ID: 17827069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
